Table 4 summarizes the most relevant studies performed by cooperative multicenter groups worldwide in adult ALL, showing clinical outcome of patients t(4;11)(q21;q23)/MLL-AF4 positive. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.